wat een paniek weer om niets.
nog geen antwoord van de FDA, dus nog steeds hetzelfde als 7 weken gelden.
ik kom net thuis, en zie dat we weer terug bij af zijn, maar het enige dat ik kan vinden is dit :
Hemispherx Biopharma Inc. (HEB) is yet other stock, which continues to rally on swine flu concerns. The company will provide an update on its influenza research initiatives including the experimental programs planned or underway in Pacific Rim countries, Australia, South America and the United States today (July 22).
The company is awaiting FDA approval of its experimental drug Ampligen for chronic fatigue syndrome. Ampligen is also in preclinical testing for avian flu in the U.S., Japan and Canada.
Last month, Hemispherx's collaborative influenza vaccine development partner in Japan, Biken announced its plan to invest a total of 35 billion Yen (US $350 million) to expand its Flu production capacity in Kanonji City. The Japanese research teams believe that Ampligen is an essential co-ingredient to provide experimental efficacy with the Biken vaccine.
heeft iemand de uitslag van de CC voor mij?